mitomycin has been researched along with Bile Duct Cancer in 41 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient receiving the antitumor agent mitomycin C (MMC) in combination with 5-fluorouracil and adriamycin because of adenocarcinoma of Vater's papilla manifested hemolytic-uremic syndrome (HUS) after five cycles of 5-fluorouracil-adriamycin-MMC combination chemotherapy." | 8.77 | Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy. ( Binsack, T; Mergenthaler, HG; Wilmanns, W, 1988) |
| "We assessed the effect of purified green tea catechins on chemotherapy-induced apoptosis in KMCH, CC-LP-1 and Mz-ChA-1 human cholangiocarcinoma cells, and on chemosensitivity of Mz-ChA-1 cell xenografts in nude mice." | 7.75 | Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells. ( Braconi, C; Henson, R; Lang, M; Patel, T, 2009) |
| " Then cholangiocarcinoma cells were induced to apoptosis with mitomycin." | 7.72 | [Immune response of dendritic cells acquiring antigens from apoptotic cholangiocarcinoma cells induced by mitomycin]. ( Han, BL; Pei, XT; Wu, G, 2003) |
| "A 64-year-old woman who was diagnosed as inoperable intrahepatic bile duct cancer with massive liver metastasis was treated with 5-fluorouracil (5-FU), adriamycin (ADM) and mitomycin-C (MMC)." | 7.67 | [A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy]. ( Hasegawa, H; Kozakai, M; Misu, Y; Saitoh, Y; Shikata, J; Takada, T; Tsuchiya, S; Uchiyama, K; Yasuda, H, 1988) |
| "Unresectable intrahepatic cholangiocarcinoma has a poor prognosis, with a median survival of 5 to 8 months without treatment." | 5.37 | Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. ( Albert, M; Christians, K; Fraker, D; Kiefer, MV; McNally, M; Olthoff, K; Pappas, S; Rilling, W; Robertson, M; Soulen, MC; Sun, W, 2011) |
| "A patient receiving the antitumor agent mitomycin C (MMC) in combination with 5-fluorouracil and adriamycin because of adenocarcinoma of Vater's papilla manifested hemolytic-uremic syndrome (HUS) after five cycles of 5-fluorouracil-adriamycin-MMC combination chemotherapy." | 4.77 | Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy. ( Binsack, T; Mergenthaler, HG; Wilmanns, W, 1988) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "We assessed the effect of purified green tea catechins on chemotherapy-induced apoptosis in KMCH, CC-LP-1 and Mz-ChA-1 human cholangiocarcinoma cells, and on chemosensitivity of Mz-ChA-1 cell xenografts in nude mice." | 3.75 | Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells. ( Braconi, C; Henson, R; Lang, M; Patel, T, 2009) |
| " Then cholangiocarcinoma cells were induced to apoptosis with mitomycin." | 3.72 | [Immune response of dendritic cells acquiring antigens from apoptotic cholangiocarcinoma cells induced by mitomycin]. ( Han, BL; Pei, XT; Wu, G, 2003) |
| "A 64-year-old woman who was diagnosed as inoperable intrahepatic bile duct cancer with massive liver metastasis was treated with 5-fluorouracil (5-FU), adriamycin (ADM) and mitomycin-C (MMC)." | 3.67 | [A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy]. ( Hasegawa, H; Kozakai, M; Misu, Y; Saitoh, Y; Shikata, J; Takada, T; Tsuchiya, S; Uchiyama, K; Yasuda, H, 1988) |
| "Four patients with gallbladder cancer and two with bile duct cancer were treated with mitomycin C, carboquone, 5-fluorouracil and OK-432 (MQF-OK therapy) plus tegafur (FT) or UFT." | 3.67 | [MQF-FT and MQF-UFT in gallbladder and bile duct cancer]. ( Fukushi, G; Itoh, T; Kimura, M; Kimura, T; Kishibe, T; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y; Tsushima, K, 1988) |
| " Main adverse events grades 2/3/4 were (n): leukocytopenia 3/2/2, anemia 13/4/0, thrombocytopenia 3/1/0, nausea/vomiting 2/1/0, diarrhea 5/1/0, hand-foot-skin reaction 7/0/0." | 2.75 | Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma. ( Ernst, T; Hochhaus, A; Hofheinz, RD; Hofmann, WK; Kripp, M; Kruth, J; Lukan, N; Merx, K; Nissen, J, 2010) |
| "Gallbladder cancer is an aggressive tumor." | 2.46 | [Chemotherapy in gallbladder carcinoma]. ( Abahssain, H; Afchain, P; Errihani, H; Ismaili, N; Melas, N; Rabti, HM; Rahali, R, 2010) |
| " Nausea and vomiting occurred as adverse event (AE) in eight out of 25 treatments (32%), with seven of eight events (87." | 1.46 | Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and Efficacy. ( Albrecht, T; Michalik, K; Nolte-Ernsting, C; Pereira, PL; Pützler, M; Schicho, A; Stroszczynski, C; Wiggermann, P, 2017) |
| "Unresectable intrahepatic cholangiocarcinoma has a poor prognosis, with a median survival of 5 to 8 months without treatment." | 1.37 | Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. ( Albert, M; Christians, K; Fraker, D; Kiefer, MV; McNally, M; Olthoff, K; Pappas, S; Rilling, W; Robertson, M; Soulen, MC; Sun, W, 2011) |
| " The current study was performed to evaluate the outcome of patients with advanced hepatic hilar duct carcinoma who received external beam radiotherapy (EBRT) combined with transarterial chemotherapy and infusion of a vasoconstrictor." | 1.32 | Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma. ( Hori, Y; Kiyosue, H; Komatsu, E; Matsumoto, A; Matsumoto, S; Mori, H; Tomonari, K; Wakisaka, M, 2004) |
| "Lymph node metastasis was not present." | 1.31 | [Lymph node and peritoneum metastases of bile duct cancer responding to chronochemotherapy--a case report]. ( Iesato, H; Morishita, Y; Nakagami, K; Ohwada, S; Ohya, T; Sasaki, T; Sugitani, K; Takahashi, T; Yokomori, T, 2000) |
| " Thus, both intraarterial and intraportal chemotherapy combined with decollateralization by silicone rubber sheeting seems to be effective for advanced cholangiocarcinoma and metastatic carcinoma." | 1.28 | [Intraarterial and intraportal chemotherapy combined with decollateralization for cholangiocellular carcinoma and metastatic liver cancer]. ( Fukuda, I; Furukawa, H; Imaoka, S; Ishikawa, O; Masutani, S; Nagano, H; Ohashi, I; Oohigashi, H; Sasaki, Y; Yasuda, T, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (24.39) | 18.7374 |
| 1990's | 6 (14.63) | 18.2507 |
| 2000's | 10 (24.39) | 29.6817 |
| 2010's | 14 (34.15) | 24.3611 |
| 2020's | 1 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Thorgersen, EB | 1 |
| Melum, E | 1 |
| Folseraas, T | 1 |
| Larsen, SG | 1 |
| Line, PD | 1 |
| Miyata, T | 1 |
| Beppu, T | 1 |
| Imamura, YU | 1 |
| Hayashi, H | 1 |
| Imai, K | 1 |
| Chikamoto, A | 1 |
| Yamashita, YI | 1 |
| Fukubayashi, K | 1 |
| Ishiko, T | 1 |
| Baba, H | 1 |
| Wirasorn, K | 1 |
| Ngamprasertchai, T | 1 |
| Khuntikeo, N | 1 |
| Pakkhem, A | 1 |
| Ungarereevittaya, P | 1 |
| Chindaprasirt, J | 1 |
| Sookprasert, A | 1 |
| Patkowski, W | 1 |
| Stankiewicz, R | 1 |
| Grąt, M | 1 |
| Krasnodębski, M | 1 |
| Kornasiewicz, O | 1 |
| Krawczyk, M | 1 |
| Huang, GL | 1 |
| Shen, DY | 1 |
| Cai, CF | 1 |
| Zhang, QY | 1 |
| Ren, HY | 1 |
| Chen, QX | 1 |
| Konstantinidis, IT | 1 |
| Groot Koerkamp, B | 1 |
| Do, RK | 1 |
| Gönen, M | 1 |
| Fong, Y | 1 |
| Allen, PJ | 1 |
| D'Angelica, MI | 1 |
| Kingham, TP | 1 |
| DeMatteo, RP | 1 |
| Klimstra, DS | 1 |
| Kemeny, NE | 1 |
| Jarnagin, WR | 1 |
| Schicho, A | 1 |
| Pereira, PL | 1 |
| Pützler, M | 1 |
| Michalik, K | 1 |
| Albrecht, T | 1 |
| Nolte-Ernsting, C | 1 |
| Stroszczynski, C | 1 |
| Wiggermann, P | 1 |
| Lang, M | 1 |
| Henson, R | 2 |
| Braconi, C | 1 |
| Patel, T | 2 |
| Liu, ZH | 1 |
| He, YP | 1 |
| Zhou, Y | 1 |
| Zhang, P | 1 |
| Qin, H | 1 |
| Kruth, J | 1 |
| Nissen, J | 1 |
| Ernst, T | 1 |
| Kripp, M | 1 |
| Lukan, N | 1 |
| Merx, K | 1 |
| Hofmann, WK | 1 |
| Hochhaus, A | 1 |
| Hofheinz, RD | 1 |
| Abahssain, H | 1 |
| Afchain, P | 1 |
| Melas, N | 1 |
| Ismaili, N | 1 |
| Rahali, R | 1 |
| Rabti, HM | 1 |
| Errihani, H | 1 |
| Kim, K | 1 |
| Chie, EK | 1 |
| Jang, JY | 1 |
| Kim, SW | 1 |
| Han, SW | 1 |
| Oh, DY | 1 |
| Im, SA | 1 |
| Kim, TY | 1 |
| Bang, YJ | 1 |
| Ha, SW | 1 |
| Kiefer, MV | 1 |
| Albert, M | 1 |
| McNally, M | 1 |
| Robertson, M | 1 |
| Sun, W | 1 |
| Fraker, D | 1 |
| Olthoff, K | 1 |
| Christians, K | 1 |
| Pappas, S | 1 |
| Rilling, W | 1 |
| Soulen, MC | 1 |
| Vogl, TJ | 2 |
| Naguib, NN | 1 |
| Nour-Eldin, NE | 1 |
| Bechstein, WO | 1 |
| Zeuzem, S | 1 |
| Trojan, J | 1 |
| Gruber-Rouh, T | 1 |
| Kuhlmann, JB | 1 |
| Euringer, W | 1 |
| Spangenberg, HC | 1 |
| Breidert, M | 1 |
| Blum, HE | 1 |
| Harder, J | 1 |
| Fischer, R | 1 |
| Wu, G | 1 |
| Han, BL | 1 |
| Pei, XT | 1 |
| Matsumoto, S | 1 |
| Kiyosue, H | 1 |
| Komatsu, E | 1 |
| Wakisaka, M | 1 |
| Tomonari, K | 1 |
| Hori, Y | 1 |
| Matsumoto, A | 1 |
| Mori, H | 1 |
| Itoh, Y | 1 |
| Mizushima, T | 1 |
| Sugiura, T | 1 |
| Hori, S | 1 |
| Ito, T | 1 |
| Mizuno, H | 1 |
| Hoki, M | 1 |
| Souma, Y | 1 |
| Kainuma, S | 1 |
| Yamanaka, H | 1 |
| Ozawa, H | 1 |
| Kanou, T | 1 |
| Nakamori, Y | 1 |
| Iwase, K | 1 |
| Naus, PJ | 1 |
| Bleeker, G | 1 |
| Wehbe, H | 1 |
| Meng, F | 1 |
| Zangos, S | 1 |
| Eichler, K | 1 |
| Selby, JB | 1 |
| Bauer, RW | 1 |
| Shitara, K | 1 |
| Ikami, I | 1 |
| Munakata, M | 1 |
| Muto, O | 1 |
| Sakata, Y | 3 |
| Smith, GW | 1 |
| Bukowski, RM | 1 |
| Hewlett, JS | 1 |
| Groppe, CW | 1 |
| Kelm, C | 1 |
| Henneking, K | 1 |
| Zimmermann, T | 1 |
| Vollerthun, M | 1 |
| Padberg, W | 1 |
| Tsuji, Y | 1 |
| Imai, M | 1 |
| Katsuki, Y | 1 |
| Yasuda, T | 2 |
| Nishimura, A | 1 |
| Koyama, K | 2 |
| Tanaka, J | 2 |
| Sato, Y | 1 |
| Seki, H | 1 |
| Kato, Y | 1 |
| Umezawa, A | 1 |
| Nakagami, K | 1 |
| Takahashi, T | 1 |
| Sugitani, K | 1 |
| Sasaki, T | 1 |
| Yokomori, T | 1 |
| Iesato, H | 1 |
| Ohya, T | 1 |
| Ohwada, S | 1 |
| Morishita, Y | 1 |
| Niinobu, T | 1 |
| Shibata, T | 2 |
| Fukushima, Y | 1 |
| Kitada, M | 1 |
| Tukahara, Y | 1 |
| Hata, S | 1 |
| Ikeda, K | 1 |
| Hayashida, H | 1 |
| Fuzita, J | 1 |
| Takahashi, Y | 1 |
| Nakamura, T | 1 |
| Suzuki, R | 1 |
| Shimano, T | 1 |
| Takami, M | 1 |
| Ishida, T | 1 |
| Kubota, S | 1 |
| Takezawa, T | 1 |
| Mori, Y | 2 |
| Takakuwa, T | 1 |
| Tsushima, K | 2 |
| Shiratori, Y | 1 |
| Sakamoto, J | 1 |
| Koeda, J | 1 |
| Yamada, Y | 1 |
| Soma, N | 1 |
| Tamura, K | 1 |
| Yoshiwara, A | 1 |
| Soma, Y | 1 |
| Nagano, H | 2 |
| Sasaki, Y | 2 |
| Imaoka, S | 2 |
| Masutani, S | 1 |
| Ohashi, I | 1 |
| Ishikawa, O | 2 |
| Oohigashi, H | 1 |
| Furukawa, H | 2 |
| Fukuda, I | 2 |
| Kato, S | 1 |
| Asanuma, Y | 1 |
| Wada, H | 1 |
| Ohigashi, H | 1 |
| Kabuto, T | 1 |
| Yamashita, K | 2 |
| Hirai, K | 2 |
| Aoki, Y | 2 |
| Sakai, T | 2 |
| Noguchi, H | 2 |
| Miyazono, K | 1 |
| Abe, M | 1 |
| Tanikawa, K | 1 |
| Saitu, H | 1 |
| Nakayama, K | 1 |
| Fujimoto, T | 1 |
| Tanaka, M | 1 |
| Majima, Y | 1 |
| Miyazone, K | 1 |
| Kubo, Y | 1 |
| Iguchi, H | 1 |
| Murasawa, M | 1 |
| Yanada, J | 1 |
| Terashima, Y | 1 |
| Masuda, K | 1 |
| Takasaki, H | 1 |
| Uchida, Y | 1 |
| Shigemitsu, O | 1 |
| Oka, K | 1 |
| Fujitomi, Y | 1 |
| Ichimanda, M | 1 |
| Shibata, O | 1 |
| Shirabe, J | 1 |
| Mergenthaler, HG | 1 |
| Binsack, T | 1 |
| Wilmanns, W | 1 |
| Uchiyama, K | 1 |
| Takada, T | 1 |
| Yasuda, H | 1 |
| Hasegawa, H | 1 |
| Tsuchiya, S | 1 |
| Misu, Y | 1 |
| Saitoh, Y | 1 |
| Shikata, J | 1 |
| Kozakai, M | 1 |
| Fukushi, G | 1 |
| Suzuki, H | 1 |
| Kimura, T | 1 |
| Kimura, M | 1 |
| Tamura, Y | 1 |
| Kishibe, T | 1 |
| Saitoh, S | 1 |
| Itoh, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Trial of Induction Gemcitabine, Cisplatin and Nab-Paclitaxel Triplet Chemotherapy Followed by Gemcitabine, Cisplatin and Radioembolization for the Treatment of Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma[NCT05422690] | Phase 2 | 16 participants (Anticipated) | Interventional | 2024-01-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for mitomycin and Bile Duct Cancer
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
[Chemotherapy in gallbladder carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Capecitabine; Cisplatin; Deoxyc | 2010 |
[Adjuvant chemical treatment for bile duct cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Biliary Tract Surgical Procedur | 2006 |
Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
Topics: Adenocarcinoma; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasm | 1988 |
3 trials available for mitomycin and Bile Duct Cancer
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Ne | 2010 |
Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bile | 2012 |
35 other studies available for mitomycin and Bile Duct Cancer
| Article | Year |
|---|---|
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.
Topics: Antineoplastic Agents, Alkylating; Bile Duct Neoplasms; Cholangiocarcinoma; Cholangitis, Sclerosing; | 2018 |
A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chol | 2019 |
Adjuvant chemotherapy in resectable cholangiocarcinoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; | 2013 |
Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic | 2014 |
β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; beta | 2015 |
Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; | 2016 |
Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and Efficacy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile D | 2017 |
Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Bile Duct Neoplasms; Blotting, Western; Camellia sinens | 2009 |
Establishment and identification of the human multi-drug-resistant cholangiocarcinoma cell line QBC939/ADM.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Su | 2011 |
Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; B | 2012 |
Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile | 2011 |
Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemoembolization, Th | 2012 |
[Immune response of dendritic cells acquiring antigens from apoptotic cholangiocarcinoma cells induced by mitomycin].
Topics: Antigens, Neoplasm; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Co | 2003 |
Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile D | 2004 |
[A case of postoperative liver metastasis from bile duct carcinoma responding to transarterial chemoembolization].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemoembo | 2006 |
Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfami | 2007 |
Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: results in hepatic metastases.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antine | 2008 |
Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrah | 2008 |
Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma.
Topics: Adenoma, Bile Duct; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms | 1984 |
[Palliative therapy of primary liver tumors].
Topics: Adenoma, Bile Duct; Adolescent; Adult; Aged; alpha-Fetoproteins; Angiography; Antineoplastic Combine | 1993 |
[A case of liver metastasis from bile duct cancer effectively treated with hepatic artery infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Drug Administration Schedule; E | 1994 |
Experience in twenty patients with carcinoma of hilar bile duct treated by resection, targeting chemotherapy and intracavitary irradiation.
Topics: Adult; Aged; Bile Duct Neoplasms; Brachytherapy; Chemotherapy, Adjuvant; Cobalt Radioisotopes; Combi | 1993 |
[Lymph node and peritoneum metastases of bile duct cancer responding to chronochemotherapy--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cisplatin | 2000 |
[Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
Topics: Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatoc | 2000 |
[A new method of in vitro chemosensitivity test using multicellular spheroids of cholangiocarcinoma cell line cocultured with fibroblasts].
Topics: Adenocarcinoma; Bile Duct Neoplasms; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Mitomyci | 1992 |
[Cases of advanced cholangiocarcinoma showing partial response by the combination chemotherapy including protracted continuous infusion of 5-FU combined with intravenous administration of low-dose leucovorin and intra-arterial administration of MMC and CQ
Topics: Adenoma, Bile Duct; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carbazilqui | 1991 |
[Intraarterial and intraportal chemotherapy combined with decollateralization for cholangiocellular carcinoma and metastatic liver cancer].
Topics: Adenoma, Bile Duct; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile | 1990 |
New strategy for treatment of carcinoma of the hilar bile duct.
Topics: Adenoma, Bile Duct; Adult; Bile Duct Neoplasms; Bile Ducts; Brachytherapy; Charcoal; Cobalt Radioiso | 1989 |
[Intra-arterial and intraportal therapy combined with decollateralization in unresectable cholangiocellular carcinoma--a case report].
Topics: Adenoma, Bile Duct; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, | 1989 |
[Treatment with degradable starch microspheres (DSM) in malignant hepatic tumors-clinical experience of implantable drug delivery system (Port-A-Cath)].
Topics: Adenoma, Bile Duct; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carci | 1988 |
[Assessment of therapeutic effects by transcatheter arterial embolization (TAE) in hepatic malignant tumors with degradable starch microspheres (DSM)].
Topics: Adenoma, Bile Duct; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Doxorubicin; Embolization, | 1988 |
[A case of cholangiocarcinoma treated by transcatheter arterial embolization].
Topics: Adenoma, Bile Duct; Aged; Bile Duct Neoplasms; Cisplatin; Embolization, Therapeutic; Female; Gelatin | 1988 |
[A case of abdominal wall fistula due to cholangioma].
Topics: Abdominal Muscles; Adenoma, Bile Duct; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neo | 1985 |
[A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Int | 1988 |
[MQF-FT and MQF-UFT in gallbladder and bile duct cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Car | 1988 |